Search Results - "Niaz, M J"

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma by Ramirez‐Fort, M. K., Meier‐Schiesser, B., Lachance, K., Mahase, S. S., Church, C. D., Niaz, M. J., Liu, H., Navarro, V., Nikolopoulou, A., Kazakov, D. V., Contassot, E., Nguyen, D. P., Sach, J., Hadravsky, L., Sheng, Y., Tagawa, S. T., Wu, X., Lange, C. S., French, L. E., Nghiem, P. T., Bander, N. H.

“…Backgrounds Folate Hydrolase‐1 (FOLH1; PSMA) is a type II transmembrane protein, luminally expressed by solid tumour neo‐vasculature. Monoclonal antibody…”
Get full text

849PDPreliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC) by Tagawa, S T, Osborne, J R, Hackett, A, Niaz, M J, Cooley, V, Christos, P, Vlachostergios, P J, Thomas, C, Gracey, L, Beltran, H, Molina, A M, Nanus, D M, Babich, J, Vallabhajosula, S, Sartor, O, Ballman, K, Bander, N H

“…Abstract Background PSMA is overexpressed in PC with limited expression in other organs. PC is radiosensitive with dose-response. Dose-fractionation allows…”
Get full text